Search results
AstraZeneca admits Covishield jab raises TTS risk. Should you be worried?
Investing.com· 4 days agoNew Delhi, April 30 (IANS) Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is...
The man with the longest-lasting COVID-19 infection: Case study
Becker’s Hospital Review· 2 days agoThe person with the longest consecutive COVID-19 infection was a 72-year-old man in Amsterdam who was documented to have the infection for 612 days, Scientific American reported May 1. The man ...
Ziyad Al-Aly
Time Magazine· 1 day agoFind out why Ziyad Al-Aly is on the TIME100 Health list.
Can nasal Neosporin fight COVID? Surprising new research suggests it works
Salon.com· 6 days agoFour years ago, when COVID-19 first began to spread globally, it didn't just damage our physical...
Navy's tech scout, Poulsbo business network partner to enhance Kitsap startup ecosystem
Kitsap Sun via Yahoo News· 4 days agoApparently, not only private hospitals need cutting-edge air disinfection technology that prevents...
Study finds metformin reduces COVID-19 viral load, viral rebound
Medical Xpress· 1 day agoA team of University of Minnesota researchers found that metformin, a drug commonly used to treat...
Controversial virus-hunting scientist skewered at US COVID-origins hearing
Nature· 3 days agoLawmakers interrogated Peter Daszak over his ties to China and whether his organisation, EcoHealth...
2,931 Shares in Hologic, Inc. (NASDAQ:HOLX) Acquired by Golden State Equity Partners
ETF DAILY NEWS· 5 days ago(NASDAQ:HOLX – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,931 ...
Top Chinese COVID-19 scientist protests lab eviction
Semafor via Yahoo News· 3 days agoThe Chinese scientist widely credited with being the first to sequence the COVID-19 virus’s genome claimed to have been “evicted” from his Shanghai lab.
BioVie secures $13.1M funding from US Department of Defense for Long COVID treatment
Proactive Investors· 4 days agoBioVie Inc (NASDAQ:BIVI), a clinical-stage company focused on innovative drug therapies, announced...